<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Ms. DeGETTE:H.R. 2011.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3--Commerce Clause[Page H2939]</pre>]]></constitutionalAuthorityStatementText>
    <originChamber>House</originChamber>
    <createDate>2019-04-02T07:12:08Z</createDate>
    <recordedVotes />
    <calendarNumbers />
    <version>1.0.0</version>
    <committees>
      <billCommittees>
        <item>
          <subcommittees />
          <systemCode>hsif00</systemCode>
          <chamber>House</chamber>
          <type>Standing</type>
          <activities>
            <item>
              <date>2019-04-01T16:02:40Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <name>Energy and Commerce Committee</name>
        </item>
      </billCommittees>
    </committees>
    <sponsors>
      <item>
        <fullName>Rep. DeGette, Diana [D-CO-1]</fullName>
        <firstName>DIANA</firstName>
        <bioguideId>D000197</bioguideId>
        <byRequestType />
        <party>D</party>
        <middleName />
        <lastName>DEGETTE</lastName>
        <identifiers>
          <lisID>1479</lisID>
          <gpoId>7859</gpoId>
          <bioguideId>D000197</bioguideId>
        </identifiers>
        <district>1</district>
        <state>CO</state>
      </item>
    </sponsors>
    <congress>116</congress>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <committeeReports />
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionCode>H11100</actionCode>
        <links />
        <type>IntroReferral</type>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <actionDate>2019-04-01</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
      </item>
      <item>
        <actionCode>Intro-H</actionCode>
        <links />
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <actionDate>2019-04-01</actionDate>
        <committee />
      </item>
      <item>
        <actionCode>1000</actionCode>
        <links />
        <type>IntroReferral</type>
        <text>Introduced in House</text>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <actionDate>2019-04-01</actionDate>
        <committee />
      </item>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
    </actions>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Allergies</name>
          </item>
          <item>
            <name>Blood and blood diseases</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Immunology and vaccination</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <introducedDate>2019-04-01</introducedDate>
    <updateDate>2019-07-02T21:52:50Z</updateDate>
    <titles>
      <item>
        <title>To amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biologics license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009.</title>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <title>Protecting Access to Biosimilars Act of 2019</title>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <title>Protecting Access to Biosimilars Act of 2019</title>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <title>Protecting Access to Biosimilars Act of 2019</title>
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <notes />
    <cboCostEstimates />
    <laws />
    <billType>HR</billType>
    <relatedBills>
      <item>
        <congress>116</congress>
        <latestTitle>Lower Health Care   Costs Act</latestTitle>
        <type>S</type>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <number>1895</number>
        <latestAction>
          <actionDate>2019-06-26</actionDate>
          <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
        </latestAction>
      </item>
      <item>
        <congress>116</congress>
        <latestTitle>Protecting Access to Biosimilars Act of 2019</latestTitle>
        <type>S</type>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <number>1140</number>
        <latestAction>
          <actionDate>2019-04-11</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
      </item>
    </relatedBills>
    <cosponsors>
      <item>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>Tom</firstName>
        <lastName>Reed</lastName>
        <fullName>Rep. Reed, Tom [R-NY-23]</fullName>
        <state>NY</state>
        <sponsorshipDate>2019-04-01</sponsorshipDate>
        <district>23</district>
        <sponsorshipWithdrawnDate />
        <middleName />
        <identifiers>
          <lisID>1982</lisID>
          <bioguideId>R000585</bioguideId>
          <gpoId>8090</gpoId>
        </identifiers>
        <bioguideId>R000585</bioguideId>
        <party>R</party>
      </item>
      <item>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>Kim</firstName>
        <lastName>Schrier</lastName>
        <fullName>Rep. Schrier, Kim [D-WA-8]</fullName>
        <state>WA</state>
        <sponsorshipDate>2019-04-01</sponsorshipDate>
        <district>8</district>
        <sponsorshipWithdrawnDate />
        <middleName />
        <identifiers>
          <bioguideId>S001216</bioguideId>
          <gpoId />
          <lisID>2458</lisID>
        </identifiers>
        <bioguideId>S001216</bioguideId>
        <party>D</party>
      </item>
      <item>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>Brett</firstName>
        <lastName>Guthrie</lastName>
        <fullName>Rep. Guthrie, Brett [R-KY-2]</fullName>
        <state>KY</state>
        <sponsorshipDate>2019-04-01</sponsorshipDate>
        <district>2</district>
        <sponsorshipWithdrawnDate />
        <middleName />
        <identifiers>
          <bioguideId>G000558</bioguideId>
          <lisID>1922</lisID>
          <gpoId>7954</gpoId>
        </identifiers>
        <bioguideId>G000558</bioguideId>
        <party>R</party>
      </item>
      <item>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Glenn</firstName>
        <lastName>Grothman</lastName>
        <fullName>Rep. Grothman, Glenn [R-WI-6]</fullName>
        <state>WI</state>
        <sponsorshipDate>2019-05-22</sponsorshipDate>
        <district>6</district>
        <sponsorshipWithdrawnDate />
        <middleName />
        <identifiers>
          <bioguideId>G000576</bioguideId>
          <gpoId />
          <lisID>2276</lisID>
        </identifiers>
        <bioguideId>G000576</bioguideId>
        <party>R</party>
      </item>
      <item>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Dan</firstName>
        <lastName>Crenshaw</lastName>
        <fullName>Rep. Crenshaw, Dan [R-TX-2]</fullName>
        <state>TX</state>
        <sponsorshipDate>2019-06-27</sponsorshipDate>
        <district>2</district>
        <sponsorshipWithdrawnDate />
        <middleName />
        <identifiers>
          <lisID>2443</lisID>
          <bioguideId>C001120</bioguideId>
          <gpoId />
        </identifiers>
        <bioguideId>C001120</bioguideId>
        <party>R</party>
      </item>
    </cosponsors>
    <billNumber>2011</billNumber>
    <latestAction>
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <actionDate>2019-04-01</actionDate>
      <links />
    </latestAction>
    <textVersions>
      <item>
        <date>2019-04-01T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr2011ih/xml/BILLS-116hr2011ih.xml</url>
          </item>
        </formats>
        <type>Introduced in House</type>
      </item>
    </textVersions>
    <amendments />
    <summaries>
      <billSummaries />
    </summaries>
    <title>Protecting Access to Biosimilars Act of 2019</title>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

